Company Overview

Update
Founded:
2005
Founders:
Rosana Kapeller
Headquarters:
Hardwick, MA
Funding:
$99.50M
Categories:
Biotechnology

Aileron Therapeutics is a biopharmaceutical company that develops a class of drugs called Stapled Peptides.

Description

Update

Aileron Therapeutics, based in Cambridge, Massachusetts, is a biopharmaceutical company that was founded in 2005 to develop and advance a class of drugs called Stapled Peptides. Stapled Peptides represent the first general solution, or "scaffold" for modulating intracellular protein-protein interactions that are critical control points to nearly all functions of a cell. The ability to target and regulate these control points affords the unique opportunity to exploit potentially thousands of currently "undruggable" cellular targets with applications in all human diseases.

Aileron’s proprietary technology locks peptides into their biologically active shape, mimicking the structures found in nature, and ultimately endows the peptide with unique properties, including efficient cell penetration, high affinity binding to large target protein surfaces and excellent stability within the body.

Current Team (5)

Update

Board Members and Advisors (7)

Update

Funding Rounds (5) - $99.50M

Update

Investors (6)

Update

Offices/Locations (2)

Update
  • Office

    Cambridge, MA

    USA

  • HQ

    840 Memorial Drive, 2nd Floor

    Cambridge

    Hardwick, MA MA 02139

    USA

Images (1)

Update
  • 0ae9efd06d39bfd0e5bb2e52da61c140